Aliso Viejo, CA—Bausch & Lomb has received FDA approval to market the fourth-generation of the only FDA-approved accommodating lens (Crystalens HD). The lens was first approved in November 2003.
As new techniques in cataract surgery present so, too, do new complications and challenges in the management of such cases, said Gregg Kokame, MD, MMM, medical director of The Retina Center at Pali Momi, and clinical professor, Division of Ophthalmology, University of Hawaii School of Medicine, Honolulu.
Allergan Inc. has expanded its artificial tears and eye drops product offerings with the addition of ketotifen fumarate ophthalmic solution (Refresh Eye Itch Relief), an over-the-counter eye drop for patients with itchy eyes due to allergies.
Oral corticosteroid therapy is essential for ocular sarcoidosis. A sub-Tenon's triamcinolone infusion, however, is useful for older patients to avoid the side effects of corticosteroids. Managing ocular sarcoidosis often requires vitrectomy for fibrotic lesions and photocoagulation for ischemic retinopathy and macroaneurysms, said Nobuyuki Ohguro, MD, Osaka University Medical School, Osaka, Japan.
Patients who have masquerade syndromes—underlying disorders that present with signs and symptoms that appear to indicate idiopathic uveitis—are among the most challenging cases to ophthalmologists, said Scott Whitcup, MD.
Do pressure-independent factors play a role in glaucoma? That would seem to be the case, since the disease progresses in many patients despite IOP reduction. Enter a new line of thinking about the disease, neuroprotection, which was the topic of a symposium held here in conjunction with the World Ophthalmology Congress.
Adaptive optics scanning laser ophthalmoscope (SLO) imaging allows visualization of the minute details of the retina that were not visible previously and that can help explain visual disturbances, said Srinivas Sadda, MD, Doheny Eye Institute, University of Southern California, Los Angeles.
There is much to be learned about nocturnal—and, more importantly, sleeping—IOP if ophthalmologists are going to optimize glaucoma therapies, said Yaniv Barkana, MD, Department of Ophthalmology, Assaf Harofeh Medical Center, Israel.
The newer generation of a dual-optic accommodating IOL (Synchrony, Visiogen) is easy to implant, centers well, provides good distance visual acuity, and demonstrates good safety in terms of potential posterior capsule opacification development, according to H. Burkhard Dick, MD.
